Ruminantbiotech
NZ, NZ · 1 known investors
Find your way into Ruminantbiotech
310 people in our graph can introduce you to the Ruminantbiotech team.
Sign up to see every warm intro you have to Ruminantbiotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ruminantbiotech team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ruminant Biotech develops a rumen bolus that releases bromoform to reduce methane emissions from cattle by approximately 70%, supporting low-carbon livestock farming. The product targets dairy and beef producers seeking to lower greenhouse gas emissions while maintaining pasture-based grazing systems.
Founders & leadership
TB

Tom BreenChief Executive OfficerTom Breen is Chief Executive Officer of Ruminant Biotech, which develops rumen boluses to reduce methane emissions from cattle. He has background experience in agribusiness leadership and domestic and international market development.
Investors · 1
Regeneration.VClisted by Regeneration.VCRedondo Beach · $1M – $3M
How we know: Regeneration.VC's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Ruminantbiotech do?
- Ruminant Biotech develops a rumen bolus that releases bromoform to reduce methane emissions from cattle by approximately 70%, supporting low-carbon livestock farming. The product targets dairy and beef producers seeking to lower greenhouse gas emissions while maintaining pasture-based grazing systems.
- Who are Ruminantbiotech's investors?
- Ruminantbiotech's investors include Regeneration.VC.
- Where is Ruminantbiotech headquartered?
- Ruminantbiotech is headquartered in NZ, NZ.

